Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma

Abstract Background The current standard of care for classical Hodgkin lymphoma (HL) is multiagent chemotherapy with or without radiation. In patients who relapse or fail to respond, additional high-dose chemotherapy with autologous hematopoietic stem cell transplantation (AHSCT) can improve progres...

Full description

Bibliographic Details
Main Authors: Patrick B. Johnston, Lauren C. Pinter-Brown, Ghulam Warsi, Kristen White, Radhakrishnan Ramchandren
Format: Article
Language:English
Published: BMC 2018-05-01
Series:Experimental Hematology & Oncology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40164-018-0103-z